BATM Advanced Communications Ltd.

Equities

BVC

IL0010849045

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 16:35:24 03/06/2024 BST			5-day change	1st Jan Change
18.05 ^GBX	+0.84%		-2.43%	-10.86%

05-02	National Research Council of Italy Selects BATM Advanced Communications Ltd. for Prestigious EU-Funded TB Diagnostics Programme	CI
05-02	BATM Advanced Communications Ltd. Selected for Tb Diagnostics Programme	CI

BATM Advanced Communications Ltd. Approves Appointment of Dr. Avigdor Shafferman as an Additional External Director on its Board

March 07, 2016 at 07:12 am

BATM Advanced Communications Ltd. approved the appointment of Dr. Avigdor Shafferman as an additional external director on the board of the company in the extraordinary general meeting held on February 12, 2015.

Latest news about BATM Advanced Communications Ltd.

National Research Council of Italy Selects BATM Advanced Communications Ltd. for Prestigious EU-Funded TB Diagnostics Programme	05-02	CI
BATM Advanced Communications Ltd. Selected for Tb Diagnostics Programme	05-02	CI
BATM wins three-year deal providing Edgility platform to Totalplay	04-18	AN
BATM Advanced Communications Lands Three-year Edge Computing Deal in Mexico	04-18	MT
BATM Signs Three-Year Agreement to Provide its Edgility Edge Virtualisation Platform and Accompanying Hardware to Totalplay	04-18	CI
BATM Advanced Communications inks contract with Cemex for Edgility	04-08	AN
BATM Awards New Edgility Contract from Cemex, S.A.B. de C.V	04-08	CI
BATM Advanced ink USD2.3 million orders	03-26	AN
BATM Advanced Communications Bags $2 Million Order for Cybersecurity Services	03-26	MT
BATM Advanced Communications Limited Receives $2.3 Million Cyber Security Orders for its Solution and Development of Quantum Key Distribution Integration	03-26	CI
BATM Advanced Communications annual profit hurt by cost rise	03-12	AN
Earnings Flash (BVC.L) BATM ADVANCED COMMUNICATIONS Posts FY23 Revenue $122.8M	03-12	MT
Earnings Flash (BVC.L) BATM ADVANCED COMMUNICATIONS LD Posts FY23 Loss $-0.000	03-12	MT
BATM Advanced Communications Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-12	CI
Transcript : BATM Advanced Communications Ltd., 2023 Pre Recorded Earnings Call, Mar 12, 2024	03-11
BATM Advanced Communications Ltd. Seeks M&A Opportunities	03-11	CI
BATM Advanced Communications Wins $3 Million Cyber Security Order	30/10/23	MT
BATM Advanced Communications wins USD3 million cyber security order	30/10/23	AN
Pearson upgrades annual guidance; HSBC profit misses	30/10/23	AN
Batm Advanced Communications Limited Receives New $3 Million Cyber Security Order	30/10/23	CI
BATM makes additional investment in ADOR Diagnostics	23/10/23	AN
BATM Advanced Communications Invests $3.5 Million in ADOR Diagnostics	23/10/23	MT
Ador Diagnostics S.r.l announced that it expects to receive $7.5 million in funding from BATM Advanced Communications Ltd. and other investors.	22/10/23	CI
BATM lands new deal to deploy platform to US emergency services	16/10/23	AN
BATM Advanced Communications Wins Contact from US Emergency Connectivity Services Provider	16/10/23	MT

Chart BATM Advanced Communications Ltd.

Duration

Period

More charts

Company Profile

BATM Advanced Communications Ltd. is an Israel-based company engaged in the development, production and marketing of medical products, as well as data communication products. The Company has two operating divisions: Telecommunications and BATM Medical. The Telecommunications division develops and offers telecom network solutions, IP surveillance solutions, software services and Cyber Security solutions. The Telecommunications offers its products to telecom operators in developed markets. BATM Medical is a manufacturer and developer of laboratory diagnostics, including in-vitro diagnostic systems and reagents to detect viral infections, to diagnose immune system diseases and for the measurement of human hormone responses. BATM Medical, which focuses on developing countries in Eastern Europe and Asia, also manufactures sterilizers and medical waste management solutions, and distributes brands of other diagnostic equipment suppliers to emerging market countries.

Sector

Biotechnology & Medical Research

Calendar

18/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for BATM Advanced Communications Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
BATM ADVANCED COMMUNICATIONS LTD.	-10.86%	101M
EXACT SCIENCES CORPORATION	-39.42%	8.27B
GUARDANT HEALTH, INC.	+1.33%	3.35B
IOVANCE BIOTHERAPEUTICS, INC.	+2.95%	2.34B
BGI GENOMICS CO., LTD.	-19.81%	2.02B
VERACYTE, INC.	-23.12%	1.62B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+33.59%	1.16B
SEEGENE, INC.	-7.21%	713M
CAREDX, INC	+11.33%	696M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-32.45%	488M

Bio Diagnostics & Testing